Takeda Pharmaceutical (TAK) Exchange Rate Effect (2018 - 2026)
Takeda Pharmaceutical (TAK) posted quarterly Exchange Rate Effect of $39.9 million for Q2 2026, up 336.92% year-over-year from $9.1 million in Q2 2025, and up 468.94% quarter-over-quarter from $7.0 million in Q1 2026.
Takeda Pharmaceutical (TAK) Exchange Rate Effect (2018 - 2026) Analysis & Trends
Takeda Pharmaceutical's Exchange Rate Effect history runs 9 years deep, the most recent figure standing at $39.9 million for Q2 2026.
- In Q2 2026, Exchange Rate Effect rose 336.92% year-over-year to $39.9 million; the TTM figure through Jun 2026 stood at $283.4 million (up 234.93% YoY), while the FY2026 annual figure was $229.0 million, up 406.4% from the prior year.
- Exchange Rate Effect for Q2 2026 stood at $39.9 million, up from $7.0 million in the prior quarter.
- The five-year high for Exchange Rate Effect was $173.9 million in Q2 2022, with the low at -$280.1 million in Q3 2024.
- The 5-year median for Exchange Rate Effect is $55.6 million (2024), against an average of $39.6 million.
- The sharpest annual moves came in 2022 and 2024: Exchange Rate Effect surged 10358.94% in 2022, then slumped 1111.37% in 2024.
- Takeda Pharmaceutical's Exchange Rate Effect stood at -$67.8 million in 2022, then soared by 68.92% to -$21.1 million in 2023, then surged by 814.13% to $150.5 million in 2024, then dropped by 3.09% to $145.8 million in 2025, then slumped by 72.66% to $39.9 million in 2026.
- Business Quant data shows TAK's Exchange Rate Effect at $39.9 million in Q2 2026, $7.0 million in Q1 2026, and $145.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.87 Mn |
| Jun 30, 2026 | 39.87 Mn |
| Mar 31, 2026 | 7.01 Mn |
| Mar 31, 2026 | 7.01 Mn |
| Dec 31, 2025 | 145.84 Mn |
| Dec 31, 2025 | 145.84 Mn |
| Sep 30, 2025 | 90.70 Mn |
| Sep 30, 2025 | 90.70 Mn |
| Jun 30, 2025 | -16.83 Mn |
| Jun 30, 2025 | -16.83 Mn |
| Mar 31, 2025 | -63.58 Mn |
| Mar 31, 2025 | -63.58 Mn |
| Dec 31, 2024 | 150.49 Mn |
| Dec 31, 2024 | 150.49 Mn |
| Sep 30, 2024 | -280.13 Mn |
| Sep 30, 2024 | -280.13 Mn |
| Jun 30, 2024 | 110.62 Mn |
| Jun 30, 2024 | 110.62 Mn |
| Mar 31, 2024 | 71.26 Mn |
| Mar 31, 2024 | 71.26 Mn |